Cargando…
Myopia Control with a Novel Peripheral Gradient Soft Lens and Orthokeratology: A 2-Year Clinical Trial
Objective. To evaluate the degree of axial elongation with soft radial refractive gradient (SRRG) contact lenses, orthokeratology (OK), and single vision (SV) spectacle lenses (control) during a period of 1 year before treatment and 2 years after treatment. Methods. This was a prospective, longitudi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641166/ https://www.ncbi.nlm.nih.gov/pubmed/26605331 http://dx.doi.org/10.1155/2015/507572 |
_version_ | 1782400150722838528 |
---|---|
author | Pauné, Jaime Morales, Hari Armengol, Jesús Quevedo, Lluisa Faria-Ribeiro, Miguel González-Méijome, José M. |
author_facet | Pauné, Jaime Morales, Hari Armengol, Jesús Quevedo, Lluisa Faria-Ribeiro, Miguel González-Méijome, José M. |
author_sort | Pauné, Jaime |
collection | PubMed |
description | Objective. To evaluate the degree of axial elongation with soft radial refractive gradient (SRRG) contact lenses, orthokeratology (OK), and single vision (SV) spectacle lenses (control) during a period of 1 year before treatment and 2 years after treatment. Methods. This was a prospective, longitudinal, nonrandomized study. The study groups consisted of 30, 29, and 41 children, respectively. The axial length (AL) was measured during 2 years after recruitment and lens fitting. Results. The baseline refractive sphere was correlated significantly (Spearman's Rho (ρ) correlation = 0.542; P < 0.0001) with the amount of myopia progression before baseline. After 2 years, the mean myopia progression values for the SRRG, OK, and SV groups were −0.56 ± 0.51, −0.32 ± 0.53, and −0.98 ± 0.58 diopter, respectively. The results represent reductions in myopic progression of 43% and 67% for the SRRG and OK groups, respectively, compared to the SV group. The AL increased 27% and 38% less in the SRRG and OK groups, respectively compared with the SV group at the 2-year visit (P < 0.05). Axial elongation was not significantly different between SRRG and OK (P = 0.430). Conclusion. The SRRG lens significantly decreased AL elongation compared to the SV control group. The SRRG lens was similarly effective to OK in preventing myopia progression in myopic children and adolescent. |
format | Online Article Text |
id | pubmed-4641166 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-46411662015-11-24 Myopia Control with a Novel Peripheral Gradient Soft Lens and Orthokeratology: A 2-Year Clinical Trial Pauné, Jaime Morales, Hari Armengol, Jesús Quevedo, Lluisa Faria-Ribeiro, Miguel González-Méijome, José M. Biomed Res Int Clinical Study Objective. To evaluate the degree of axial elongation with soft radial refractive gradient (SRRG) contact lenses, orthokeratology (OK), and single vision (SV) spectacle lenses (control) during a period of 1 year before treatment and 2 years after treatment. Methods. This was a prospective, longitudinal, nonrandomized study. The study groups consisted of 30, 29, and 41 children, respectively. The axial length (AL) was measured during 2 years after recruitment and lens fitting. Results. The baseline refractive sphere was correlated significantly (Spearman's Rho (ρ) correlation = 0.542; P < 0.0001) with the amount of myopia progression before baseline. After 2 years, the mean myopia progression values for the SRRG, OK, and SV groups were −0.56 ± 0.51, −0.32 ± 0.53, and −0.98 ± 0.58 diopter, respectively. The results represent reductions in myopic progression of 43% and 67% for the SRRG and OK groups, respectively, compared to the SV group. The AL increased 27% and 38% less in the SRRG and OK groups, respectively compared with the SV group at the 2-year visit (P < 0.05). Axial elongation was not significantly different between SRRG and OK (P = 0.430). Conclusion. The SRRG lens significantly decreased AL elongation compared to the SV control group. The SRRG lens was similarly effective to OK in preventing myopia progression in myopic children and adolescent. Hindawi Publishing Corporation 2015 2015-10-28 /pmc/articles/PMC4641166/ /pubmed/26605331 http://dx.doi.org/10.1155/2015/507572 Text en Copyright © 2015 Jaime Pauné et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Pauné, Jaime Morales, Hari Armengol, Jesús Quevedo, Lluisa Faria-Ribeiro, Miguel González-Méijome, José M. Myopia Control with a Novel Peripheral Gradient Soft Lens and Orthokeratology: A 2-Year Clinical Trial |
title | Myopia Control with a Novel Peripheral Gradient Soft Lens and Orthokeratology: A 2-Year Clinical Trial |
title_full | Myopia Control with a Novel Peripheral Gradient Soft Lens and Orthokeratology: A 2-Year Clinical Trial |
title_fullStr | Myopia Control with a Novel Peripheral Gradient Soft Lens and Orthokeratology: A 2-Year Clinical Trial |
title_full_unstemmed | Myopia Control with a Novel Peripheral Gradient Soft Lens and Orthokeratology: A 2-Year Clinical Trial |
title_short | Myopia Control with a Novel Peripheral Gradient Soft Lens and Orthokeratology: A 2-Year Clinical Trial |
title_sort | myopia control with a novel peripheral gradient soft lens and orthokeratology: a 2-year clinical trial |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641166/ https://www.ncbi.nlm.nih.gov/pubmed/26605331 http://dx.doi.org/10.1155/2015/507572 |
work_keys_str_mv | AT paunejaime myopiacontrolwithanovelperipheralgradientsoftlensandorthokeratologya2yearclinicaltrial AT moraleshari myopiacontrolwithanovelperipheralgradientsoftlensandorthokeratologya2yearclinicaltrial AT armengoljesus myopiacontrolwithanovelperipheralgradientsoftlensandorthokeratologya2yearclinicaltrial AT quevedolluisa myopiacontrolwithanovelperipheralgradientsoftlensandorthokeratologya2yearclinicaltrial AT fariaribeiromiguel myopiacontrolwithanovelperipheralgradientsoftlensandorthokeratologya2yearclinicaltrial AT gonzalezmeijomejosem myopiacontrolwithanovelperipheralgradientsoftlensandorthokeratologya2yearclinicaltrial |